Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0AP4V
|
|||
| Drug Name |
Pyridoindole derivative 2
|
|||
| Synonyms |
PMID25656651-Compound-22b
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Company |
UNIVERSITA' DEGLI STUDI DI MILANO-BICOCCA UNIVERSITE DE GENEVE UNIVERSITE CLAUDE BERNARD LYON 1
|
|||
| Structure |
 |
Download2D MOL |
||
| Formula |
C19H14N2
|
|||
| Canonical SMILES |
C1=CC=C(C=C1)C=CC2=CC3=C(NC4=CC=CC=C43)N=C2
|
|||
| InChI |
1S/C19H14N2/c1-2-6-14(7-3-1)10-11-15-12-17-16-8-4-5-9-18(16)21-19(17)20-13-15/h1-13H,(H,20,21)/b11-10+
|
|||
| InChIKey |
UNSLEGIUCMXDGG-ZHACJKMWSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Fusion protein Bcr-Abl (Bcr-Abl) | Target Info | Inhibitor | [1] |
| Target's Patent Info | Fusion protein Bcr-Abl (Bcr-Abl) | Target's Patent Info | [1] | |
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Bcr-Abl tyrosine kinase inhibitors: a patent review.Expert Opin Ther Pat. 2015 Apr;25(4):397-412. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.